AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10348083 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective Behavioral Index (OBI) - Dysfunctional Behaviors
Number of subjects: 136
Study 10348083 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective Behavioral Index (OBI) - Service Utilization
Number of subjects: 136
Study 10348083 — intervention group
Group type: COMPARATOR
Intervention: Service Utilization
Number of subjects: 136
Study 8602314 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen-progestin preparation
Number of subjects: 63
Study 8602314 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 63
Study 8602314 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 63
Study 1761336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral aspirin
Number of subjects: 77
Study 1761336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 7067071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide (300 micrograms/day)
Number of subjects: 19
Study 7067071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3882355 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethopyrazine (2 capsules of 250 mg trimethoprim + 200 mg sulfamethopyrazine per capsule on the 1st day and 1 capsule for the following 14 days)
Number of subjects: 72
Study 3882355 — intervention group
Group type: COMPARATOR
Intervention: trimethoprim-sulfamethoxazole (2 capsules of trimethoprim 80 mg + sulfamethoxazole 400 mg per capsule twice daily for 15 days)
Number of subjects: 72
Study 31451902 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation (ACI) for patella defects
Number of subjects: 73
Study 31451902 — intervention group
Group type: COMPARATOR
Intervention: Autologous chondrocyte implantation (ACI) for femoral condyle defects
Number of subjects: 73
Study 30062632 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app only
Number of subjects: 69
Study 30062632 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin examination reminders
Number of subjects: 69
Study 30062632 — intervention group
Group type: EXPERIMENTAL
Intervention: Accountability partner
Number of subjects: 69
Study 30062632 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders and accountability partner
Number of subjects: 69
Study 27359338 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 16
Study 27359338 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 16
Study 27359338 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham tDCS)
Number of subjects: 16
Study 24926954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal L-tryptophan (L-Trp) at 0.075 kcal/min (total 6.75 kcal)
Number of subjects: 10
Study 24926954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal L-tryptophan (L-Trp) at 0.15 kcal/min (total 13.5 kcal)
Number of subjects: 10
Study 24926954 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study 22783845 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy-software group (low-interactive learning environment)
Number of subjects: 85
Study 22783845 — intervention group
Group type: COMPARATOR
Intervention: Complex-software group (high-interactive e-learning program)
Number of subjects: 85
Study 20046170 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro‐ESR
Number of subjects: 80
Study 20046170 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 80
Study 20046170 — intervention group
Group type: EXPERIMENTAL
Intervention: I/T ratio
Number of subjects: 80
Study 20046170 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 80
Study 20046170 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute neutrophil count (ANC)
Number of subjects: 80
Study 20046170 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 neonates without signs of sepsis)
Number of subjects: 80
Study 18419949 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil (5 mg) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection.
Number of subjects: 43
Study 18419949 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (5 ml) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection (Control group).
Number of subjects: 43
Study 16227864 — intervention group
Group type: EXPERIMENTAL
Intervention: Design of Experiments (DOE)
Number of subjects: 0
Study 16227864 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple interventions assessed alone or in combination
Number of subjects: 0
Study 16227864 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 12208225 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase treatment
Number of subjects: 144
Study 10394020 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD), median cumulative dose 4050 mg, median duration 18 days
Number of subjects: 572
Study 10394020 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD)
Number of subjects: 572
Study 10394020 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 572
Study 7555617 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg or 25 mg ketoprofen
Number of subjects: 345
Study 7555617 — intervention group
Group type: COMPARATOR
Intervention: 200 mg ibuprofen
Number of subjects: 345
Study 7555617 — intervention group
Group type: COMPARATOR
Intervention: 275 mg naproxen sodium
Number of subjects: 345
Study 1777547 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurobiol 25,000
Number of subjects: 6
Study 1777547 — intervention group
Group type: COMPARATOR
Intervention: Eurobiol
Number of subjects: 6
Study 7049820 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg oxprenolol
Number of subjects: 30
Study 7049820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30904750 — intervention group
Group type: EXPERIMENTAL
Intervention: NetballSmart Dynamic Warm-up
Number of subjects: 81
Study 28114922 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly home monitoring of symptoms (CFRSD-CRISS and FEV1)
Number of subjects: 100
Study 28114922 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 100
Study 25669933 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus combined with lower dose tacrolimus
Number of subjects: 0
Study 25669933 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (combination regimen minus everolimus)
Number of subjects: 0
Study 25029834 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture after arthroscopic debridement
Number of subjects: 78
Study 25029834 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic debridement only
Number of subjects: 78
Study 23786504 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 175
Study 23786504 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 175
Study 23786504 — intervention group
Group type: COMPARATOR
Intervention: Indirect assessment
Number of subjects: 175
Study 23786504 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct measurement
Number of subjects: 175
Study 19479852 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-IFNalpha monoclonal antibody (mAb) therapy
Number of subjects: 0
Study 17457444 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (PD)
Number of subjects: 143
Study 17457444 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 143
Study 17457444 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal transplant (TX)
Number of subjects: 143
Study 17457444 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 143
Study 15141920 — intervention group
Group type: EXPERIMENTAL
Intervention: New test for coordinated exertion of force
Number of subjects: 48
Study 15141920 — intervention group
Group type: COMPARATOR
Intervention: Pursuit‐rotor test
Number of subjects: 48
Study 15141920 — intervention group
Group type: COMPARATOR
Intervention: Pegboard test
Number of subjects: 48
Study 14656555 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid PTSD and AD treatment group
Number of subjects: 0
Study 14656555 — intervention group
Group type: COMPARATOR
Intervention: PTSD alone treatment group
Number of subjects: 0
Study 14656555 — intervention group
Group type: COMPARATOR
Intervention: AD alone treatment group
Number of subjects: 0
Study 10520149 — intervention group
Group type: EXPERIMENTAL
Intervention: Restored teeth (80 specimens) subjected to bacterial challenge for 36 days
Number of subjects: 132
Study 10520149 — intervention group
Group type: COMPARATOR
Intervention: Unrestored teeth (12 specimens)
Number of subjects: 132
Study 10520149 — intervention group
Group type: EXPERIMENTAL
Intervention: Restored teeth (40 specimens) challenged in acidified broth (pH 4.0)
Number of subjects: 132
Study 8542488 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered 1% diphenhydramine
Number of subjects: 30
Study 8542488 — intervention group
Group type: COMPARATOR
Intervention: Plain 1% diphenhydramine
Number of subjects: 30
Study 1668099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 8
Study 1668099 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.64% stannous fluoride
Number of subjects: 8
Study 1668099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile saline
Number of subjects: 8
Study 1668099 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 8
Study 7104148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 14
Study 7104148 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study 29385578 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenomic NRT prescribing (based on OPRM1 genotype or nicotine dependence questionnaire score)
Number of subjects: 40
Study 29385578 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT patches with prescribed doses of oral NRT
Number of subjects: 40
Study 29385578 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT prescribing tailored to phenotype
Number of subjects: 40
Study 23168396 — intervention group
Group type: EXPERIMENTAL
Intervention: X-STOP interspinous spacer
Number of subjects: 55
Study 24707475 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific strength training (SST, n = 18)
Number of subjects: 42
Study 24707475 — intervention group
Group type: EXPERIMENTAL
Intervention: General fitness training (GFT, n = 16)
Number of subjects: 42
Study 24707475 — intervention group
Group type: COMPARATOR
Intervention: Reference group without physical training (REF, n = 8)
Number of subjects: 42
Study 24707475 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (CON, n = 20)
Number of subjects: 42
Study 22144539 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus enteric-coated didanosine plus lopinavir and ritonavir for 7 days
Number of subjects: 169
Study 22144539 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus enteric-coated didanosine for 30 days
Number of subjects: 169
Study 22144539 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen 1 for 30 days
Number of subjects: 169
Study 22144539 — intervention group
Group type: COMPARATOR
Intervention: Historical comparison group (received prenatal zidovudine and SD-NVP)
Number of subjects: 169
Study 20453481 — intervention group
Group type: EXPERIMENTAL
Intervention: Washing the biopsy needle with povidone-iodine (Group 1, n = 84)
Number of subjects: 180
Study 20453481 — intervention group
Group type: COMPARATOR
Intervention: No washing of the biopsy needle (Group 2, n = 96)
Number of subjects: 180
Study 20453481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 180
Study 17666602 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocervical curettage (ECC)
Number of subjects: 1119
Study 17666602 — intervention group
Group type: COMPARATOR
Intervention: Colposcopically directed biopsy
Number of subjects: 1119
Study 17666602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sensitivity of ECC and biopsy
Number of subjects: 1119
Study 15599137 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%)
Number of subjects: 36
Study 15599137 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%) + S(+) ketamine (75 mg)
Number of subjects: 36
Study 15599137 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%) + Ketorolac (60 mg)
Number of subjects: 36
Study 15599137 — intervention group
Group type: COMPARATOR
Intervention: Control (Bupivacaine only)
Number of subjects: 36
Study 12102303 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin and ethambutol
Number of subjects: 75
Study 12102303 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin, ethambutol and isoniazid
Number of subjects: 75
Study 9523804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric 5% lidocaine
Number of subjects: 200
Study 9523804 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric 5% prilocaine
Number of subjects: 200
Study 8130055 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 1 mg as a bolus i.v. injection 15 s before propofol
Number of subjects: 22
Study 8130055 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 22
Study 2632532 — intervention group
Group type: EXPERIMENTAL
Intervention: metronidazole 400mg tid
Number of subjects: 137
Study 1091161 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 35
Study 1091161 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 35
Study 31941466 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated patients' feedback during Objective Structured Clinical Exam (OSCE) on communication skills
Number of subjects: 80
Study 31941466 — intervention group
Group type: COMPARATOR
Intervention: Pre-test scores on Liverpool Communication Skills Assessment Scale (LCSAS)
Number of subjects: 80
Study 31299077 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque Reduction Neutralization Test (PRNT)
Number of subjects: 3990
Study 31299077 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-Linked Immunosorbent Assay (ELISA)
Number of subjects: 3990
Study 31299077 — intervention group
Group type: COMPARATOR
Intervention: ELISA threshold of 51.7 ELISA units/mL
Number of subjects: 3990
Study 31299077 — intervention group
Group type: COMPARATOR
Intervention: Correlation between PRNT and ELISA
Number of subjects: 3990
Study 28701597 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone low-dose infusion at 0.375 μg/kg/min
Number of subjects: 0
Study 28701597 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone medium-dose infusion at 0.5 μg/kg/min
Number of subjects: 0
Study 28701597 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone high-dose infusion at 0.75 μg/kg/min
Number of subjects: 0
Study 28701597 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25307771 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnoy's solution (CS)
Number of subjects: 110
Study 25307771 — intervention group
Group type: COMPARATOR
Intervention: 10% neutral buffered formalin solution (NBF)
Number of subjects: 110
Study 24046430 — intervention group
Group type: EXPERIMENTAL
Intervention: Cassava (CASS)
Number of subjects: 240
Study 24046430 — intervention group
Group type: EXPERIMENTAL
Intervention: Broken rice (BROK)
Number of subjects: 240
Study 24046430 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn (CRN)
Number of subjects: 240
Study 24046430 — intervention group
Group type: COMPARATOR
Intervention: Nonmolted control (CONT)
Number of subjects: 240
Study 21929764 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (TP) 1 μg/kg/hour
Number of subjects: 60
Study 21929764 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) 0.04 U/minute
Number of subjects: 60
Study 21929764 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 60
Study 21929764 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (TP)
Number of subjects: 60
Study 21929764 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP)
Number of subjects: 60
Study 19219665 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 48
Study 19219665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 17068314 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (selective serotonin reuptake inhibitor); specific dosage and duration not mentioned.
Number of subjects: 0
Study 17068314 — intervention group
Group type: COMPARATOR
Intervention: Placebo; specific dosage and duration not mentioned.
Number of subjects: 0
Study 12640354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (CEF) 20 mg/kg/d for 10 days
Number of subjects: 100
Study 12640354 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (AMC) 25 mg/kg/d for 10 days
Number of subjects: 100
Study 11242548 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic case management using an interactive voice response system (IVR)
Number of subjects: 0
Study 11242548 — intervention group
Group type: COMPARATOR
Intervention: General project (control group)
Number of subjects: 0
Study 9344167 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral controlled-release (CR)
Number of subjects: 12
Study 9344167 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal (TDD)
Number of subjects: 12
Study 9344167 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal (TMD)
Number of subjects: 12
Study 8199078 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oestrogen/progestin treatment
Number of subjects: 68
Study 8199078 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic sequential oestrogen/progestin treatment
Number of subjects: 68
Study 8199078 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 68
Study 8199078 — intervention group
Group type: EXPERIMENTAL
Intervention: Five years treatment with oestradiol/norethisterone
Number of subjects: 68
Study 2889258 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 5 mg
Number of subjects: 0
Study 2889258 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 10 mg
Number of subjects: 0
Study 2889258 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 0
Study 30526528 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide
Number of subjects: 416
Study 30526528 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg hydrochlorothiazide
Number of subjects: 416
Study 30526528 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrochlorothiazide
Number of subjects: 416
Study 30526528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study 28813255 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years parenting intervention
Number of subjects: 387
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of vegetables tried at age 14 months
Number of subjects: 340
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of fruits and noncore foods tried at age 14 months
Number of subjects: 340
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a variety of fruits and vegetables
Number of subjects: 340
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited noncore food exposure from an early age
Number of subjects: 340
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fussiness at age 14 months
Number of subjects: 340
Study 26198582 — intervention group
Group type: EXPERIMENTAL
Intervention: Child body mass index z score
Number of subjects: 340
Study 23506581 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal nerve blockade
Number of subjects: 18
Study 23506581 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 18
Study 21885675 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of lipocalin 2
Number of subjects: 272
Study 21885675 — intervention group
Group type: EXPERIMENTAL
Intervention: Total and free leptin levels
Number of subjects: 272
Study 21885675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipocalin 2 levels
Number of subjects: 272
Study 21885675 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA-IR
Number of subjects: 272
Study 19467049 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat treatment at 440 degrees C for 30 min
Number of subjects: 0
Study 19467049 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat treatment at 440 degrees C for 10 min
Number of subjects: 0
Study 19467049 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat treatment at 500 degrees C for 30 min
Number of subjects: 0
Study 19467049 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat treatment at 500 degrees C for 10 min
Number of subjects: 0
Study 19467049 — intervention group
Group type: COMPARATOR
Intervention: Nonheat-treated specimens
Number of subjects: 0
Study 16461145 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat (25 g)
Number of subjects: 27
Study 16461145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked wheat challenge
Number of subjects: 27
Study 16461145 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocation dose
Number of subjects: 27
Study 16461145 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE
Number of subjects: 27
Study 16461145 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin test with commercial wheat extract
Number of subjects: 27
Study 15560810 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental test whitening toothpaste
Number of subjects: 23
Study 15560810 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 23
Study 15560810 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial whitening toothpaste
Number of subjects: 23
Study 11771000 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine phosphate at a concentration of 4 mg/mL
Number of subjects: 20
Study 11771000 — intervention group
Group type: COMPARATOR
Intervention: Saline phosphate provocation
Number of subjects: 20